Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MR Imaging of Inflammatory Responses in the Central Nervous System With Ferumoxytol-Enhanced MRI

NCT02452216 is registered in ClinicalTrials.gov with Michael Iv as lead sponsor.

NCT NCT02452216
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02452216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MR Imaging of Inflammatory Responses in the Central Nervous System With Ferumoxytol-Enhanced MRI
Lead sponsor
Michael Iv
Phase
Phase 1
Overall status
Completed
Start date
June 10, 2015
Completion date
January 12, 2017
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain cancer, brain injury, brain tumors, central nervous system degenerative disorder, central nervous system infectious disorder, central nervous system vascular malformation, hemorrhagic cerebrovascular accident, ischemic cerebrovascular accident, primary brain neoplasm